North Chicago Business
-
Abbott: FDA wants more info on CertriadMar 29, 2010 11:00 pm - AstraZeneca Plc and Abbott Laboratories said U.S. regulators requested additional information on their Certriad heart treatment. The drugmakers, in a statement today, di...
-
Small businesses see pros, cons of new health care lawMar 24, 2010 11:00 pm - Small businesses will either thrive or struggle to survive under the nation's new health care law. Those two sides of the debate are offered by U.S. Rep. Melissa Bean, a...
-
Feds warn of risks in component of Abbott's SimcorMar 18, 2010 11:00 pm - NEW YORK -- The Food and Drug Administration said Friday the highest available dose of Zocor, a component in cholesterol drugs, can cause muscle damage as well as severe...
-
Abbott sues to block generic form of TriLipix as drug questionedMar 14, 2010 11:00 pm - Abbott Laboratories sued to prevent Impax Laboratories Inc. from selling a generic version of the cholesterol drug TriLipix until 2025. Impax said in a statement it is s...
-
Abbott to pay $450 million for Facet BiotechMar 09, 2010 10:00 pm - Abbott Laboratories, maker of the arthritis medicine Humira, succeeded in its bid for Facet Biotech Corp. by offering 54 percent more than Biogen Idec Inc. in its reject...
-
Abbott may be partner for Chi-MedMar 03, 2010 10:00 pm - Hutchison China MediTech Ltd., the pharmaceutical company controlled by Hong Kong billionaire Li Ka-shing, aims to find a partner this year for its experimental treatmen...
-
Abbott HIV drug being studied for possible heart harmFeb 22, 2010 10:00 pm - Two HIV drugs made by Abbott Laboratories and Roche Holding AG may be linked to heart-rhythm disorders when used together, U.S. regulators said, citing data gathered as ...
-
Convention center pondered for former Lakehurst mall siteJan 26, 2010 10:00 pm - Could the former Lakehurst Shopping Center site in Waukegan become the home of a $70 million convention center? The multipurpose center would host major conventions, tra...
-
Abbott profit little changed as costs offset salesJan 26, 2010 10:00 pm - NEW YORK -- Abbott Laboratories said Wednesday its fourth-quarter profit was flat on higher costs, but sales of the company's diverse mix of drugs, devices and nutrition...
-
Judge upholds Abbott's loss over glucose monitor claimJan 24, 2010 10:00 pm - Abbott Laboratories' loss in its bid to get more than $42 million from Becton, Dickinson & Co. and Nova Biomedical Corp. over a patent-infringement claim was upheld by a...